Biohaven closes $200M public offering at $7.50 per share Nov 13, 2025 04:05PM
Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M Nov 13, 2025 04:05PM
Biohaven prices $175 million public offering at $7.50 per share Nov 12, 2025 07:15AM
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares Nov 12, 2025 07:15AM
TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'This Pipeline Is Impressive', 'Buy BHVN' May 29, 2025 07:29AM


Mar 4, 2025 10:39AM TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'BHV-1300 Is Crushing Its Target'
Nov 13, 2024 11:18AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $75 at TD Cowen
Oct 2, 2024 04:05PM Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Oct 1, 2024 07:43AM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 1, 2024 06:14AM Biohaven Pharma (BHVN) Prices 5.26M Share Offering at $47.50/sh
Oct 1, 2024 06:00AM Biohaven Announces Pricing of $250 Million Public Offering of Common Shares
Sep 23, 2024 01:59PM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Jun 25, 2024 10:32AM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
May 29, 2024 02:18PM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
May 28, 2024 09:50AM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Apr 22, 2024 04:05PM Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Apr 18, 2024 06:00AM Biohaven Pharma (BHVN) Prices 5.6M Share Offering at $41/sh
Apr 18, 2024 06:00AM Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
Oct 5, 2023 04:05PM Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Oct 3, 2023 04:48AM Biohaven Pharma (BHVN) Prices 10.23M Share Offering at $22/sh
Oct 2, 2023 11:56PM Biohaven Announces Pricing of $225 Million Public Offering of Common Shares
Oct 25, 2022 08:21PM Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Oct 21, 2022 05:31AM Biohaven Pharma (BHVN) Prices 25M Share Offering at $10.50/sh
Oct 20, 2022 10:30PM Biohaven Announces Pricing of Public Offering of Common Shares
Oct 5, 2021 10:40AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $165 at Cowen
Aug 9, 2021 10:49AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $140 at Cowen
Jul 7, 2021 11:36AM Biohaven Pharmaceuticals (BHVN) Gains Following Sales Surge for Migraine Drug NURTEC ODT
Jul 7, 2021 10:38AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $130 at Cowen on Nurtec Momentum
Nov 9, 2020 10:51AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $90 at Cowen
Jun 15, 2020 07:16AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $80 at Cowen After Speaking with Migraine Consultants
May 8, 2020 09:19AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $60 at Cowen
Apr 17, 2020 06:52AM UPDATE: Cowen Starts Biohaven Pharmaceutical Holding (BHVN) at Outperform